Alk-Abello A/S (OCSE:ALK B) Inventories, Inventories Adjustments : kr0 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Alk-Abello A/S Inventories, Inventories Adjustments?

Alk-Abello A/S's Inventories, Inventories Adjustments for the quarter that ended in Mar. 2024 was kr0 Mil.

Alk-Abello A/S Inventories, Inventories Adjustments Historical Data

The historical data trend for Alk-Abello A/S's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello A/S Inventories, Inventories Adjustments Chart

Alk-Abello A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Inventories Adjustments

Get a 7-Day Free Trial

Alk-Abello A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Inventories Adjustments	Get a 7-Day Free Trial															-	-	-	-	-

Alk-Abello A/S Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

Alk-Abello A/S (OCSE:ALK B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello A/S (OCSE:ALK B) » Definitions » Inventories, Inventories Adjustments

Comparable Companies

Traded in Other Exchanges

AKBLF:USA ALKBc:UK 0OIR:UK 4AJ0:Germany

Address

Boge Alle 6-8, Horsholm, DNK, DK-2970

Website

https://www.alk.net

Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello A/S (OCSE:ALK B) Headlines

No Headlines